Bacopa side effects and interactions
In human trials, Bacopa monnieri has generally been tolerated, with digestive effects such as nausea, stomach upset and looser stools the most commonly reported. Formal drug-interaction studies are limited, so cautions are based mainly on how Bacopa is thought to act — including effects related to acetylcholine — rather than on documented interaction trials. Safety in pregnancy and breastfeeding has not been established.
This article answers one question. For what Bacopa Monnieri is, where it comes from and its other uses, see the Bacopa Monnieri ingredient guide.
Key findings
- Digestive side effects are the most commonly reported.
- Human drug-interaction studies are limited.
- Because Bacopa may affect acetylcholine activity, people on medicines that act on acetylcholine should ask a clinician.
- Pregnancy and breastfeeding safety is not established.
Side effects reported in human studies
Trials lasting 12 weeks or more reported Bacopa as generally tolerated. The StatPearls: Bacopa monnieri summary identifies gastrointestinal effects such as nausea, abdominal cramps and increased bowel movements as the most common adverse effects. Taking Bacopa with food is a common practical approach to reduce stomach upset, although this has not been formally tested.
Interactions: what is known and what is not
We did not identify controlled human studies measuring how Bacopa changes the blood levels of specific prescription medicines. Laboratory and mechanistic work suggests Bacopa may influence acetylcholine-related activity, and one human trial measured reduced plasma acetylcholinesterase activity (Peth-Nui et al., 2012). That makes caution reasonable with:
- Medicines that increase acetylcholine activity, such as cholinesterase inhibitors used for dementia.
- Medicines that block acetylcholine (anticholinergics), where effects could oppose each other.
- Other memory or “nootropic” supplements with cholinergic ingredients, such as huperzine A.
This list reflects mechanism-based caution, not documented interaction outcomes.
Evidence table
| Study or source | Population | What was tested | Main result | Limitations |
|---|---|---|---|---|
| StatPearls: Bacopa monnieri | Clinical summary | Bacopa monnieri use | Gastrointestinal effects most commonly reported | Narrative summary |
| Peth-Nui et al., 2012 | 60 healthy older adults | 300 or 600 mg daily, 12 weeks | Reduced plasma acetylcholinesterase activity alongside cognitive measures | Mechanistic marker, not an interaction study |
Who should ask a clinician first
- Pregnant or breastfeeding people.
- People taking dementia medicines or anticholinergic medicines.
- People with gastrointestinal conditions such as peptic ulcers.
- Anyone taking several brain or memory supplements together.
Limitations
- Few formal drug-interaction studies.
- Trials were generally short and excluded people on many medicines.
- Commercial products vary in extract and dose.
Label checks
- Check memory blends for multiple cholinergic ingredients (huperzine A, alpha-GPC, citicoline).
- Confirm the Bacopa amount and standardisation.
- Stop and seek advice if you develop persistent digestive symptoms.
Related: Bacopa dosage used in studies · Bacopa evidence review
Frequently asked questions
What are Bacopa’s side effects?
Digestive effects such as nausea, stomach upset and looser stools are most commonly reported.
Does Bacopa interact with medications?
Formal interaction studies are limited; caution is advised with medicines acting on acetylcholine.
Can I take Bacopa with huperzine A?
Combining cholinergic ingredients adds uncertainty; ask a clinician.
Is Bacopa safe in pregnancy?
Safety has not been established.
Should I take Bacopa with food?
Many people do to reduce stomach upset, although this has not been formally tested.